JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity
- PMID: 30185813
- DOI: 10.1038/s41388-018-0466-y
JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity
Abstract
Overexpression of Jumonji domain-containing 6 (JMJD6) has been reported to be associated with more aggressive breast cancer characteristics. However, the precise role of JMJD6 in breast cancer development remains unclear. Here, we demonstrate that JMJD6 has intrinsic tyrosine kinase activity and can utilize ATP and GTP as phosphate donors to phosphorylate Y39 of histone H2A.X (H2A.XY39ph). High JMJD6 levels promoted autophagy in triple negative breast cancer (TNBC) cells by regulating the expression of autophagy-related genes. The JMJD6-H2A.XY39ph axis promoted TNBC cell growth via the autophagy pathway. We show that combined inhibition of JMJD6 kinase activity and autophagy efficiently decreases TNBC growth. Together, these findings suggest an effective strategy for TNBC treatment.
Similar articles
-
Livin promotes colon cancer progression by regulation of H2A.XY39ph via JMJD6.Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22. Life Sci. 2019. PMID: 31445935
-
KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4257-4265. doi: 10.1080/21691401.2019.1673764. Artif Cells Nanomed Biotechnol. 2019. PMID: 31736361
-
Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):897-904. doi: 10.1093/abbs/gmy084. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 30060056
-
Jumonji domain-containing protein 6 protein and its role in cancer.Cell Prolif. 2020 Feb;53(2):e12747. doi: 10.1111/cpr.12747. Epub 2020 Jan 21. Cell Prolif. 2020. PMID: 31961032 Free PMC article. Review.
-
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.Front Immunol. 2022 Mar 14;13:859893. doi: 10.3389/fimmu.2022.859893. eCollection 2022. Front Immunol. 2022. PMID: 35359945 Free PMC article. Review.
Cited by
-
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.Signal Transduct Target Ther. 2019 Dec 17;4:62. doi: 10.1038/s41392-019-0095-0. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31871779 Free PMC article. Review.
-
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.Mol Cancer. 2021 Dec 20;20(1):171. doi: 10.1186/s12943-021-01464-x. Mol Cancer. 2021. PMID: 34930302 Free PMC article. Review.
-
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.Mol Cell. 2022 Aug 18;82(16):3030-3044.e8. doi: 10.1016/j.molcel.2022.06.003. Epub 2022 Jun 27. Mol Cell. 2022. PMID: 35764091 Free PMC article.
-
Approaches to develop therapeutics to treat frontotemporal dementia.Neuropharmacology. 2020 Apr;166:107948. doi: 10.1016/j.neuropharm.2020.107948. Epub 2020 Jan 8. Neuropharmacology. 2020. PMID: 31962288 Free PMC article. Review.
-
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.Int J Mol Sci. 2024 Apr 30;25(9):4935. doi: 10.3390/ijms25094935. Int J Mol Sci. 2024. PMID: 38732153 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases